Amneal Pharmaceuticals is recalling Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag, Lot AH250162.

Amneal Pharmaceuticals is recalling a pouch of magnesium sulfate used to prevent seizures from preeclampsia and eclampsia, ...

Providing magnesium sulfate to pregnant patients before delivery in the periviable period of 22-24 weeks’ gestation was not linked to better neurodevelopmental outcomes in the newborn after accounting ...

Amneal Pharmaceuticals LLC is voluntarily recalling one lot of Magnesium Sulfate in Water for Injection, USP, 4g/100mL, IV bag, to the hospital level. A Magnesium Sulfate in Water for Injection pouch ...

Magnesium sulfate given intravenously to pregnant women at risk of very preterm birth was not associated with benefit on neurological, behavioral, growth, or functional outcomes in their children at ...

Magnesium sulfate is usually the first-line prevention and treatment option for eclampsia. It may help to reduce the risk of serious outcomes, including the death of the pregnant person. Eclampsia is ...

Short-term (usually less than 48 hours) use of magnesium sulfate in obstetric care is appropriate for certain conditions and durations of treatment, according to a committee opinion from the American ...